跳转至内容
Merck
CN

主要文件

查看所有文档

1.25195

Cellvento® 4HEK Powder

Chemically defined, powder, suitable (for HEK293 cell culture)

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
41106213
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Level

500

description

shipped with cooling pack.

Dry powder medium must be supplemented with 2.5 g/L Sodium Bicarbonate. Once hydrated, medium must be supplemented with 6-10 mM L-Glutamine

product line

Cellvento®

form

dry powder

technique(s)

cell culture | mammalian: suitable

suitability

suitable (for HEK293 cell culture)

storage temp.

2-8°C

General description

Cellvento® 4HEK Medium is a chemically defined medium optimized for adeno-associated virus (AAV) production in multiple human embryonic kidney (HEK) 293 lineages. Cellvento® 4HEK Medium has been streamlined and cell culture media components incorporated to increase media stability and reduce protein oxidation. The formulation is animal component free.

Application

Cellvento® 4HEK Medium can be used as amplification and production medium for gene therapy applications. This medium enables low doubling time and high viable cell densities with multiple HEK293 cell lines. Cellvento®4HEK Medium is compatible with commonly used transfection reagents like PEI, supports AAV production and facilitates high titers of full capsids in various HEK293 lineages. This easy-to-use medium can be used for all stages like growth, transfection, and production.

Preparation Note

Dry powder medium must be supplemented with 2.5 g/LSodium Bicarbonate. Once hydrated, medium must be supplemented with 6-10 mML-Glutamine.

Legal Information

CELLVENTO is a registered trademark of Merck KGaA, Darmstadt, Germany

pictograms

Exclamation mark
GHS07

signalword

Warning

hcodes

H319

Hazard Classifications

Eye Irrit. 2

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Can AAV Continue to Deliver the Promise of Gene Therapy?

The current status and future manufacturing of AAV-based gene therapies is discussed in this podcast transcript, including how to streamline large-scale manufacturing.

Development of a Novel Cell Culture Medium for AAV Production With Multiple HEK293 Lineages and Process Optimization

Read our white paper on the development of a novel cell culture medium for AAV production with multiple HEK293 lineages and process optimization.

High Performing Platforms for Lentivirus and AAV Manufacturing

Upstream gene therapy optimization maximizes viral vector titers; partner with technology experts for HEK293, HEK293T, and Sf9 cell solutions.

查看所有文章

相关内容

Viral Vector Upstream Platforms

A transfection-based solution to viral vector production using a suspension cell line, chemically defined medium, and a process with proven performance at scale.

病毒载体上游平台

一种基于转染技术的病毒载体生产解决方案，采用悬浮细胞系、化学定义培养基，并通过经大规模验证的工艺实现。

Data Sheet